Bajaj Broking Research recommends Piramal Pharma and PTC India for the upcoming week. Nifty is expected to remain volati ...
Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...
The Nifty Pharma index closed on a negative note on Thursday. Shares of Mankind Pharma Ltd.(up 1.61 per cent), J B Chemicals ...
Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to ...
Sun Pharmaceutical Industries announces acquisition of US-based Checkpoint Therapeutics for up to USD 355 million. The Indian ...
The stock market opened in the green as the trading session for the week began on Monday, March 10, with media, metal, and pharma stocks rising the most.
3d
Zacks Investment Research on MSNPharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline UpdateNovo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...
Here are four things you should know if you're thinking of buying Recursion Pharmaceuticals stock. 1. Early innings ... of Recursion as an investment. Image source: Recursion Pharmaceuticals.
Pharmaceuticals segment sales increased 2. ... the eight major stocks performed in the previous five trading sessions. Image Source: Zacks Investment Research In the last five trading sessions ...
9d
Zacks Investment Research on MSNPharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & MoreBayer BAYRY announced its fourth-quarter and full-year 2024 results. AbbVie ABBV announced a licensing deal with Danish firm ...
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results